Eton Pharmaceuticals, Inc. ($ETON)
Filing Information
| Accession Number | 0001493152-26-032394 |
|---|---|
| Form Type | 4 |
| Filing Date | Jul 7, 2026 |
| Document | View SEC Filing |
Transactions
5
Total Shares
126,685
Total Value
$4,768,637.17
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
10% Owner | Common Stock, par value $0.001 per share | โ | Jul 2, 2026 | Sale | 65,000 | $37.39 | $2,430,031.50 | 2,710,000 | Indirect | By Opaleye, L.P. | View Details | |
10% Owner | Common Stock, par value $0.001 per share | โ | Jul 2, 2026 | Sale | 25,000 | $37.39 | $934,627.50 | 60,000 | Indirect | By Managed Account | View Details | |
10% Owner | Common Stock, par value $0.001 per share | โ | Jul 6, 2026 | Sale | 10,000 | $38.00 | $380,000.00 | 2,700,000 | Indirect | By Opaleye, L.P. | View Details | |
10% Owner | Common Stock, par value $0.001 per share | โ | Jul 7, 2026 | Sale | 20,000 | $38.37 | $767,456.00 | 2,680,000 | Indirect | By Opaleye, L.P. | View Details | |
10% Owner | Common Stock, par value $0.001 per share | โ | Jul 7, 2026 | Sale | 6,685 | $38.37 | $256,522.17 | 53,315 | Indirect | By Managed Account | View Details |